Thank you for your interest, we’ll get in touch with you shortly!
Du använder Internet Explorer, en webbläsare som slutade utvecklas 6 november 2013, för över 9 år sedan. Den 31 januari 2020 upphörde även alla säkerhetsuppdateringar vilket innebär att webbläsaren, förutom funktionella och utseendemässiga brister även kan utgöra en säkerhetsrisk. Du rekommenderas starkt att uppgradera till en modernare webbläsare, t ex Google Chrome, Mozilla Firefox eller Microsoft Edge. Tala med din systemadministratör.
FIRST UNIVERSAL AI BIO-NET INFRASTRUCTURE: The AI Bio-Net is a global network of mobile devices empowered by Engineering Physics and reinforced by A.I. algorithms which results in-place and online detection of biomolecules with a continuous screening just in seconds, and eliminates biological kit & specialized personnel requirements in Biotech Industry. We solved indirectness and digitalization problems which are main bottlenecks of Biotechnology, initiating first Bio-Blockchain environment.
Bacteria measured by everyone, everywhere – this is our vision. There are many applications where bacteria are measured today. There are even more applications where there is a need to measure bacteria. We enable people to measure and monitor bacteria everywhere through our novel detection technology that is fast, affordable, and easy-to-use. Having user-friendly products makes it possible for everyone to use them, and as a result, everyone will be able to measure bacteria, everywhere.
Digilege.no and Evaksine.no are Norway’s first digital health platforms. We want to use existing technology to solve specific and real health problems. We make healthcare easier and more accessible by combining the latest technology with knowledgeable and motivated doctors. Our platforms unable certain specific health conditions to be handled online without a regular doctor visit. All the doctors who work with us have experience from the Norwegian healthcare system.
Founded by a physiotherapist, Axomove is an e-health startup which intends to improve the rehabilitation and prevention of all physical conditions, from neurology diseases, orthopedic surgery and traumatology in rehab centers and hospitals to musculoskeletal disorders (MSK) at the workplace.
Noui is a tiny wearable bladder scanner to help the hospital staff to determine risk patients’ exact timing for catheterization or cystometry to minimise fatal cases, staffing hours and infection rates. We use electromagnetic communication, capacitance coupling method to compare the signal strengths and estimate fluidity of the bladder. It assists pharmaceutical companies to determine the time for dosing and new drug effectiveness for outpatients.
Manje is a project by Industry Frontiers AB designed to be a Swedish technology company that specialises in Internet-related medical services and products, which include a searchable online platform of hospitals in Africa, advertising technologies, search engine for wellness treatment, pharmaceuticals and flights and hotels for patients searching for treatment anywhere in Africa.
ImagineCare makes it possible for you to have contact with your healthcare provider at a distance where you continuously report your health values, both manually and via sensor technology, and answer questions about symptoms and mood. ImagineCare is your tool for gaining an increased understanding of your health and thus better control.
Digital Allergi Medical Treatement. From basis allergy tips to Immunitheraphy using mobile app. We offer Digital Patient Room for meetings, diagnostics, compliance and adherence to improve the patient well beeing, making this a better patient-doctor experience than a physical one.
Cogant™ Consulting is a Healthcare domain focused service provider. We help our clients to grow through solutions in the area of Market Entry/Business Development/Strategic interventions in South Asia and Middle East Asia.
BrainTrip has developed a rapid, scalable screening test for dementia. We use existing EEGs to measure brain waves of a person for 5 minutes and then analyze the data using our proprietary algorithms. The end-result is a biomarker for cognitive impairment, which indicates the likelihood that the person is already suffering or will suffer from dementia in the next few years.